Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Pliant Therapeutics, Inc. (PLRX)
Kuo Minnie — Chief Operating Officer
Shares
6,917
Price
$1.28
Total Value
$8.85K
Shares Held After
37,806
% of Holdings
15.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.47
Total Value
$178.80K
Shares Held After
913,839
% of Holdings
4.2%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
3,867
Price
$35.67
Total Value
$137.94K
Shares Held After
21,354
% of Holdings
15.3%
AMICUS THERAPEUTICS, INC. (FOLD)
Campbell Bradley L — Director
Shares
75,000
Price
$14.31
Total Value
$1.07M
Shares Held After
1,021,180
% of Holdings
6.8%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,083
Price
$26.11
Total Value
$132.74K
Shares Held After
25,812
% of Holdings
16.5%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,833
Price
$26.12
Total Value
$152.33K
Shares Held After
562,080
% of Holdings
1.0%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
8,567
Price
$52.10
Total Value
$446.34K
Shares Held After
194,201
% of Holdings
4.2%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
21,433
Price
$51.61
Total Value
$1.11M
Shares Held After
202,768
% of Holdings
9.6%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
14,509
Price
$26.90
Total Value
$390.28K
Shares Held After
745,188
% of Holdings
1.9%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
5,491
Price
$26.37
Total Value
$144.81K
Shares Held After
759,697
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
718
Price
$26.96
Total Value
$19.35K
Shares Held After
23,877
% of Holdings
2.9%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
512
Price
$26.46
Total Value
$13.55K
Shares Held After
24,595
% of Holdings
2.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
19,604
Price
$32.38
Total Value
$634.78K
Shares Held After
58,382
% of Holdings
25.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
39,712
Price
$31.78
Total Value
$1.26M
Shares Held After
77,986
% of Holdings
33.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
900
Price
$30.64
Total Value
$27.58K
Shares Held After
117,698
% of Holdings
0.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
254
Price
$160.70
Total Value
$40.82K
Shares Held After
306,891
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,229
Price
$159.85
Total Value
$356.31K
Shares Held After
307,145
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,967
Price
$158.99
Total Value
$948.69K
Shares Held After
309,374
% of Holdings
1.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,243
Price
$158.37
Total Value
$196.85K
Shares Held After
315,341
% of Holdings
0.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,006
Price
$156.80
Total Value
$157.74K
Shares Held After
316,584
% of Holdings
0.3%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
972
Price
$8.92
Total Value
$8.67K
Shares Held After
8,321
% of Holdings
10.5%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
10,000
Price
$26.88
Total Value
$268.80K
Shares Held After
727,770
% of Holdings
1.4%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
75,000
Price
$7.88
Total Value
$590.93K
Shares Held After
3,091,604
% of Holdings
2.4%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
76,967
Price
$6.54
Total Value
$503.36K
Shares Held After
3,166,604
% of Holdings
2.4%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
25,000
Price
$7.51
Total Value
$187.65K
Shares Held After
0
% of Holdings
100.0%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,000
Price
$3.07
Total Value
$6.14K
Shares Held After
0
% of Holdings
100.0%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
1,000
Price
$69.74
Total Value
$69.74K
Shares Held After
37,793
% of Holdings
2.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,432
Price
$4.80
Total Value
$59.67K
Shares Held After
629,943
% of Holdings
1.9%
Protagonist Therapeutics, Inc. (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
9,514
Price
$82.48
Total Value
$784.71K
Shares Held After
97,266
% of Holdings
8.9%
Protagonist Therapeutics, Inc. (PTGX)
PATEL DINESH V PH D — Director
Shares
34,438
Price
$82.48
Total Value
$2.84M
Shares Held After
580,505
% of Holdings
5.6%
Protagonist Therapeutics, Inc. (PTGX)
Ali Asif — Chief Financial Officer
Shares
8,588
Price
$82.48
Total Value
$708.34K
Shares Held After
78,077
% of Holdings
9.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.32
Total Value
$792.00
Shares Held After
268,566
% of Holdings
0.2%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
1,882
Price
$19.79
Total Value
$37.25K
Shares Held After
89,324
% of Holdings
2.1%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
726
Price
$19.79
Total Value
$14.37K
Shares Held After
51,869
% of Holdings
1.4%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
1,334
Price
$19.79
Total Value
$26.40K
Shares Held After
81,724
% of Holdings
1.6%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
909
Price
$19.79
Total Value
$17.99K
Shares Held After
1,157,310
% of Holdings
0.1%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
8,182
Price
$19.79
Total Value
$161.95K
Shares Held After
313,237
% of Holdings
2.5%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
2,203
Price
$19.79
Total Value
$43.60K
Shares Held After
78,843
% of Holdings
2.7%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
2,892
Price
$19.79
Total Value
$57.24K
Shares Held After
104,188
% of Holdings
2.7%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
2,475
Price
$19.79
Total Value
$48.99K
Shares Held After
96,363
% of Holdings
2.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$27.34
Total Value
$273.42K
Shares Held After
90,270
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
6,911
Price
$90.27
Total Value
$623.85K
Shares Held After
11,305
% of Holdings
37.9%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
3,034
Price
$30.12
Total Value
$91.38K
Shares Held After
41,011
% of Holdings
6.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$32.10
Total Value
$13.35K
Shares Held After
50,437
% of Holdings
0.8%
Arcellx, Inc. (ACLX)
Lubner David Charles — Director
Shares
6,000
Price
$75.00
Total Value
$450.00K
Shares Held After
21,659
% of Holdings
21.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,760
Price
$18.42
Total Value
$69.27K
Shares Held After
50,897
% of Holdings
6.9%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
Showing 251–300 of 1179 transactions (page 6 of 24)